UBS AG (NYSE: UBS) shares surged more than 8% on Tuesday after the Swiss financial giant reported that it swung to a second-quarter net profit of 2 billion Swiss francs ($1.9 billion) compared to a loss of CHF1.4 billion in the same period a year ago.
Shares of Unisys Corp. (NYSE: UIS) jumped as much as 11% after it announced that its second-quarter profit more than tripled to $120.2 million, or $2.77 a share, from $38.1 million, or $1.02 a share, in the year-ago quarter.
Ferro Corp. (NYSE: FOE) shot up as much as 18% on Tuesday, a day after it reported that it swung to a second-quarter profit, helped by a 36% jump in quarterly revenues. Looking ahead, the company raised its annual sales forecast.
Shares of Ultra Clean Holdings Inc. (NASDAQ: UCTT) rallied more than 14% on Tuesday, a day after it reported that it swung to a second-quarter profit as sales rose more than quadrupled. In addition, the company provided an upbeat third quarter outlook.
Cytori Therapeutics (NASDAQ: CYTX) rallied more than 3% after the company announced that it has received expanded European approval for its Celution System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue. The new indications include key medical applications such as breast reconstruction, repair of soft tissue defects, as well as the facilitation of healing certain types of wounds, such as those resulting from Crohn's disease. This broadens Cytori's ability to offer the Celution System to patients and hospitals and further supports the company's efforts to gain treatment reimbursement.
World Heart Corp. (NASDAQ: WHRT) surged as much as 4% on Tuesday. The company announced today that the Food and Drug Administration has approved the addition of ten sites to the Levacor ventricular assist device Bridge-to-Transplant clinical study. WorldHeart's pivotal BTT study is now approved to enroll patients at 20 sites in the U.S.
Disclosure: Author doesn't own any of the stocks discussed here.
